Parkinsonism & related disorders · 2026
Probable REM sleep behavior disorder marks a less levodopa-responsive phenotype in Parkinson's disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Onder Halil, Akcelebi Fatma, Comoglu Selcuk
Аннотация
BACKGROUND: Probable REM sleep behavior disorder (pRBD) is a clinically relevant phenotype in Parkinson's disease (PD), commonly associated with greater non-motor burden and a more diffuse disease profile. However, its independent clinical correlates remain incompletely defined, particularly regarding acute dopaminergic responsiveness.
OBJECTIVE: To identify independent clinical correlates of pRBD in a comprehensively phenotyped PD cohort, with particular attention to acute levodopa responsiveness.
METHODS: In this retrospective cross-sectional study, 468 patients with PD underwent multidimensional motor and non-motor assessments. Probable RBD (pRBD) was determined using an informant-based screening item derived from the Mayo Sleep Questionnaire. Acute dopaminergic responsiveness was quantified using standardized OFF-ON MDS-UPDRS part III evaluations. Multivariable logistic regression was performed to identify independent correlates of pRBD. An exploratory secondary analysis examined individual NMSS subdomains.
RESULTS: Probable RBD was identified in 158/468 patients (33.8%). In multivariable analysis, male sex (OR 1.72, 95% CI 1.07-2.75; p = 0.024), anosmia/hyposmia (OR 2.29, 95% CI 1.47-3.55; p < 0.001), constipation (OR 1.99, 95% CI 1.23-3.24; p = 0.005), and lower total levodopa response rate (OR 0.27, 95% CI 0.08-0.93; p = 0.038) were independently associated with pRBD. Among these, lower acute levodopa responsiveness represented a clinically distinctive and robust independent association. In the exploratory analysis, only the gastrointestinal NMSS subdomain remained independently associated with pRBD.
CONCLUSIONS: In PD, pRBD is independently associated with constipation, anosmia/hyposmia, male sex, and lower acute levodopa responsiveness. Reduced acute levodopa responsiveness may represent an underrecognized and clinically relevant feature of the pRBD phenotype.
OBJECTIVE: To identify independent clinical correlates of pRBD in a comprehensively phenotyped PD cohort, with particular attention to acute levodopa responsiveness.
METHODS: In this retrospective cross-sectional study, 468 patients with PD underwent multidimensional motor and non-motor assessments. Probable RBD (pRBD) was determined using an informant-based screening item derived from the Mayo Sleep Questionnaire. Acute dopaminergic responsiveness was quantified using standardized OFF-ON MDS-UPDRS part III evaluations. Multivariable logistic regression was performed to identify independent correlates of pRBD. An exploratory secondary analysis examined individual NMSS subdomains.
RESULTS: Probable RBD was identified in 158/468 patients (33.8%). In multivariable analysis, male sex (OR 1.72, 95% CI 1.07-2.75; p = 0.024), anosmia/hyposmia (OR 2.29, 95% CI 1.47-3.55; p < 0.001), constipation (OR 1.99, 95% CI 1.23-3.24; p = 0.005), and lower total levodopa response rate (OR 0.27, 95% CI 0.08-0.93; p = 0.038) were independently associated with pRBD. Among these, lower acute levodopa responsiveness represented a clinically distinctive and robust independent association. In the exploratory analysis, only the gastrointestinal NMSS subdomain remained independently associated with pRBD.
CONCLUSIONS: In PD, pRBD is independently associated with constipation, anosmia/hyposmia, male sex, and lower acute levodopa responsiveness. Reduced acute levodopa responsiveness may represent an underrecognized and clinically relevant feature of the pRBD phenotype.